Equita Adds DiaSorin to Small Cap Portfolio with 'Buy' Rating
Financial firm Equita has added DiaSorin to its small-cap portfolio and upgraded the stock to a 'buy' rating ahead of the company's upcoming quarterly results.
Crypto · News reference
Will S&P 500 open higher? Polymarket odds plunge to 28% as Wall Street digests rising Treasury yields, resilient tech, and rebounding oil.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Financial firm Equita has added DiaSorin to its small-cap portfolio and upgraded the stock to a 'buy' rating ahead of the company's upcoming quarterly results.
Trump mandates AI data centers produce their own electricity, as BlackRock's Larry Fink warns construction delays could trigger inflation.
Will the S&P 500 open higher? Polymarket odds hit 68% as Wall Street eyes Meta and Tesla earnings, booming AI demand, and $110 Brent crude.
Health care stocks climbed to record highs by midday Tuesday, with defensives and small caps leading a recovery from an early dip.
Jefferies has revised its price target for Deckers Outdoor Corporation, lowering it from $130 to $120.
Jefferies Financial Group Inc. has reported a change in its major shareholding in SDCL Efficiency Income Trust PLC, reaching a 9.106% stake in voting rights.